84 / 1674
EndoPredict
(Myriad genetics USA)
HR+ / HER2-
, T1-2, N0
FFPE samples
11 GENES
PROLIFERATION, ESTROGEN (8 genes) + 3 REF
LOCAL TEST
(providing dedicated equipment and learning phase)
RECURRENCE
(at 5 and 10 years)
LOW RISK:
+ HT / NO CHEMOTHERAPY
HIGH RISK:
+ HT / + CHEMOTHERAPY
UBE2C
BIRC5
DHCR7
STC2
AZGP1
IL65T
RBBP8
MGP